Streetbeat News

Stock Prices

SAVA

Cassava Sciences (SAVA) shares see increased volume as traders circulate unconfirmed analyst comments suggesting confirmed guidance for the completion of its first pivotal Alzheimer's trial by the end of 2024 and a potential settlement of an SEC investigation. Analysts reiterate their buy rating and $107 price target.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 6:04 pm

IYG

JPM

XLF

JPMorgan Chase & Co. (NYSE:JPM) has launched the JPMorgan Fundamental Data Science (FDS) Suite, which includes three new active ETFs on the Nasdaq Stock Exchange. These ETFs leverage data science for portfolio construction and target core equity segments. The launch is part of JPMorgan's strategy to use advanced data science techniques to navigate complex markets. Additionally, JPMorgan Payments is expanding its collaboration with PopID to introduce in-store biometric payment technology.

Portfolio Pulse from Lekha Gupta

August 08, 2024 | 6:02 pm

AMPH

Amphastar Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 6:01 pm

PTVE

Pactiv Evergreen (NASDAQ:PTVE) has received mixed analyst ratings over the past three months, with a recent trend of lowered price targets. Analysts have provided a range of 12-month price targets, with an average of $14.0, down from a previous average of $16.20. The company faces challenges in revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:01 pm

MCO

Moody's (NYSE:MCO) has significantly outperformed the market over the past 15 years, delivering an average annual return of 21.54%. A $100 investment in MCO 15 years ago would be worth $1,840.36 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:00 pm

GH

Guardant Health (NASDAQ:GH) has received a range of analyst ratings over the past three months, with a majority being bullish. Analysts have raised their 12-month price targets, reflecting an average target of $39.67, up from $35.43. The company has shown strong revenue growth but faces challenges with profitability and debt management.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:00 pm

CTRA

In the last three months, 7 analysts have shared their evaluations of Coterra Energy (NYSE:CTRA), with a mix of bullish and somewhat bullish outlooks. Analysts have set a 12-month average price target of $35.43, reflecting a 5.23% increase from the previous average. Key analysts have adjusted their ratings and price targets, with some lowering and others raising their estimates. Coterra Energy has shown solid revenue growth and strong net margins but faces challenges with ROE and ROA.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:00 pm

KMPR

Kemper (NYSE:KMPR) has received mixed analyst ratings over the past quarter, with 1 bullish and 3 somewhat bullish ratings. Analysts have raised their price targets, with an average target of $80.0, reflecting a 5.96% increase from the previous average. Despite positive analyst sentiment, Kemper faces challenges in revenue growth, net margin, ROE, and ROA, and has a higher debt-to-equity ratio than industry averages.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 6:00 pm

ETHUSD

SOLUSD

Solana (SOL) spiked to $160 following the approval of the first Solana ETF in Brazil. Traders predict further gains for Solana, potentially outperforming Ethereum (ETH). The ETF approval and investment from Binance Labs are key drivers.

Portfolio Pulse from Khyathi Dalal

August 08, 2024 | 5:56 pm

VTRS

Viatris Inc. (NASDAQ: VTRS) reported Q2 revenues of $3.797 billion, slightly above expectations, driven by strong demand for branded and generic drugs. The company raised its 2024 outlook for new product revenues and expects sales between $14.6 billion and $15.1 billion. Adjusted EPS for 2024 is projected to be slightly lower than previous guidance. VTRS stock rose 5.33% following the announcement.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 5:54 pm